German Life Sciences Stock News

XTRA:BEI
XTRA:BEIPersonal Products

Assessing Beiersdorf (XTRA:BEI) Valuation After Q1 Sales Decline And Mixed Segment Performance

Beiersdorf (XTRA:BEI) is in focus after its Q1 update showed a 4.6% decline in organic net sales, in contrast with 8.2% organic growth in Derma and weaker trends in Nivea and La Prairie. See our latest analysis for Beiersdorf. The Q1 update arrived after a difficult few months, with a 90 day share price return of 25.09% and a 1 year total shareholder return of 38.46%, which points to fading momentum despite the recently reiterated guidance. If this Q1 update has you reassessing your...
XTRA:LHA
XTRA:LHAAirlines

Is Deutsche Lufthansa (XTRA:LHA) Offering Value After Recent Share Price Pullback?

To make sense of whether Deutsche Lufthansa is attractively priced today, you first need a clear picture of what the recent share moves and fundamentals are actually telling you about value and risk. Over the last week the stock has seen a 4.3% decline, while the 30 day return is a 1.4% decline, set against a 12.8% decline year to date and a 22.0% gain over the past year. This mix can leave you wondering whether the market is reassessing the company or simply cooling after a stronger...
XTRA:AIXA
XTRA:AIXASemiconductor

A Fresh Look At AIXTRON (XTRA:AIXA) Valuation After Powerful Share Price Momentum

AIXTRON stock performance snapshot AIXTRON (XTRA:AIXA) has drawn fresh attention after recent trading, with the share price last closing at €46.62. Investors are assessing how this compares with its reported €556.552m revenue and €85.227m net income. See our latest analysis for AIXTRON. Recent trading has been strong, with a 1 day share price return of 3.07% adding to a 37.32% 1 month share price return and a 1 year total shareholder return of 344.24%. This suggests powerful momentum rather...
XTRA:RWE
XTRA:RWERenewable Energy

RWE (XTRA:RWE) Valuation Check As Nordseecluster B Contract Marks Further Offshore Wind Progress

Hitachi Energy’s new contract for automation equipment at Germany’s 900MW Nordseecluster B offshore wind project puts a spotlight on RWE (XTRA:RWE), which holds a 51% stake and operates the development. See our latest analysis for RWE. RWE’s recent news around Nordseecluster B arrives while momentum in the stock has been firm, with a 30 day share price return of 9.5% and a 1 year total shareholder return of 85.05%. If this kind of clean energy theme interests you, it could be worth widening...
XTRA:BAS
XTRA:BASChemicals

Assessing BASF (XTRA:BAS) Valuation After Recent Share Price Momentum And Conflicting Fair Value Signals

Recent performance and basic profile BASF (XTRA:BAS) has drawn fresh attention after recent trading, as investors weigh its role as a global chemical group across six segments, including Chemicals, Materials, Industrial Solutions and Agricultural Solutions. The company reports annual revenue of €59,657.0m and net income of €1,434.0m, with a market cap of about €46.7b. Recent returns over the past month and past 3 months have been positive. See our latest analysis for BASF. At a share price of...
XTRA:HABA
XTRA:HABARetail REITs

Hamborner REIT (XTRA:HABA) FFO Loss In Q4 2025 Challenges High Dividend Bull Case

Hamborner REIT (XTRA:HABA) has released its FY 2025 numbers with fourth quarter revenue of €25.955 million and basic EPS of €0.04, while the trailing twelve month line shows revenue of €101.806 million and EPS of €0.15. Over recent quarters, revenue has ranged from €24.662 million to €26.366 million and quarterly EPS has moved between €0.03 and €0.06. This gives investors a clear view of how the current run rate compares with the past year as they weigh the income profile and margin...
XTRA:MBG
XTRA:MBGAuto

Is Mercedes-Benz Group (XTRA:MBG) Now An Opportunity After Recent Share Price Weakness?

If you are wondering whether Mercedes-Benz Group shares offer good value or are pricing in too much optimism, the key is to look closely at what the numbers are actually saying about the stock. The share price last closed at €50.50, with returns of a 7.3% decline over the past week, a 2.8% decline over the past month, an 18.5% decline year to date, but a 10.8% gain over the past year. These mixed returns mean recent headlines, sentiment shifts, and changing expectations around the auto...
XTRA:ENR
XTRA:ENRElectrical

A Look At Siemens Energy (XTRA:ENR) Valuation As Green Ammonia Spotlight Grows

Green ammonia spotlight puts Siemens Energy (XTRA:ENR) in focus Recent coverage of the accelerating green ammonia market has put Siemens Energy (XTRA:ENR) in the spotlight, as investors consider its role in low carbon production and renewable energy integration. See our latest analysis for Siemens Energy. The latest focus on green ammonia and renewable integration has coincided with a strong shift in sentiment, with Siemens Energy’s 30 day share price return of 20.88% sitting within a broader...
XTRA:DTE
XTRA:DTETelecom

Assessing Deutsche Telekom (XTRA:DTE) Valuation After Recent Pullback And Longer Term Shareholder Gains

Deutsche Telekom: recent performance snapshot Deutsche Telekom (XTRA:DTE) has drawn investor attention after a period of mixed share performance, with the stock showing a 1 day return of a 4.6% decline, a 7 day return of a 3.8% decline, and a month move of a 12.9% decline. See our latest analysis for Deutsche Telekom. At a share price of €27.47, Deutsche Telekom’s recent 1 month share price return of a 12.9% decline contrasts with a 3 year total shareholder return of 35.95% and a 5 year total...
XTRA:VOW3
XTRA:VOW3Auto

Volkswagen’s China EV Pivot Tests Export Strategy And Xpeng Partnership

Volkswagen is increasing exports of China made electric vehicles to emerging markets as part of a broader reset of its China plans. The company is expanding its collaboration with Chinese EV maker Xpeng, including joint development work and technology sharing. Volkswagen has outlined plans to introduce 50 plug in hybrid and electric models in China, signaling a larger focus on locally adapted products. For investors watching XTRA:VOW3, this China push comes as the share price sits at about...
XTRA:RDC
XTRA:RDCConsumer Retailing

Assessing Redcare Pharmacy (XTRA:RDC) Valuation After 18.3% Q1 2026 Revenue Growth

Redcare Pharmacy (XTRA:RDC) reported preliminary first quarter 2026 group revenue of €848 million, up 18.3% year on year, supported by higher non-prescription sales in Germany and continued prescription momentum in Germany and Switzerland. See our latest analysis for Redcare Pharmacy. The strong first quarter revenue update and recent Supervisory Board appointments have coincided with a sharp rebound in momentum, with Redcare Pharmacy’s 30 day share price return of 55.54% contrasting with a 1...
XTRA:ALV
XTRA:ALVInsurance

European Dividend Stocks With Yields Up To 4.4%

As European markets respond to corporate earnings and geopolitical developments, the pan-European STOXX Europe 600 Index saw a notable rise of 1.91%, reflecting investor optimism amid Middle East de-escalation. In this context, dividend stocks with yields up to 4.4% can be appealing for investors seeking stable income streams, especially when considering companies with strong fundamentals that can withstand economic fluctuations and provide consistent returns.
XTRA:SAP
XTRA:SAPSoftware

Is SAP (XTRA:SAP) Offering An Opportunity After Recent Share Price Weakness?

If you are wondering whether SAP's current share price reflects its true worth, the recent swings in the stock make that question especially timely. The shares last closed at €151.16, with a 5.4% gain over the past 7 days, a 1.7% decline over 30 days, and deeper falls of 25.1% year to date and 30.2% over the last year, despite a 28.2% and 39.0% gain over 3 and 5 years respectively. Recent coverage has focused on SAP's position as a major software provider, its role in supporting enterprise...
XTRA:SUR
XTRA:SURConsumer Durables

Surteco Group (XTRA:SUR) Q4 Loss Of €9.2 Million Reinforces Bearish Profitability Narratives

Surteco Group (XTRA:SUR) has reported its FY 2025 results with fourth quarter revenue of €182.3 million and a basic EPS loss of €0.59, while on a trailing twelve month basis revenue sat at €823.8 million and EPS was a loss of €0.92. Over the past few quarters, revenue has moved from €222.8 million in Q1 2025 to €214.4 million in Q2, €204.3 million in Q3 and €182.3 million in Q4. EPS has swung between a loss of €0.33 in Q1, a smaller loss in Q2, a slight profit of €0.02 in Q3 and then a wider...
XTRA:BMW
XTRA:BMWAuto

A Look At Bayerische Motoren Werke (XTRA:BMW) Valuation After Recent Share Price Reset

Why Bayerische Motoren Werke Stock Is On Investors’ Radar Bayerische Motoren Werke (XTRA:BMW) has drawn attention after recent trading left the shares around €83.50, prompting investors to reassess the carmaker’s valuation, recent share performance, and the financial profile behind its global auto and financing operations. See our latest analysis for Bayerische Motoren Werke. Recent trading has been mixed, with a 10.22% 1 month share price return contrasting with a 13.31% year to date share...
XTRA:V1NC
XTRA:V1NCAerospace & Defense

Undiscovered Gems in Europe for April 2026

As European markets navigate a landscape of cautious optimism amid geopolitical developments and economic adjustments, the STOXX Europe 600 Index has shown resilience with a notable uptick, driven by corporate earnings and easing tensions in the Middle East. In this environment, identifying promising small-cap stocks requires a keen understanding of market dynamics and potential growth drivers that align with broader economic indicators.
XTRA:AIXA
XTRA:AIXASemiconductor

AIXTRON’s €450m Convertible Bonds Raise Dilution Questions At Elevated Valuation

AIXTRON (XTRA:AIXA) has completed a €450 million convertible bond offering due in 2031. The transaction is described as a major capital markets deal for the company, affecting its funding and capital structure. The new bonds introduce potential future share dilution depending on how and when they are converted. The bond issue follows a period of strong share price performance, with AIXTRON up 16.0% over the past week and 33.8% over the past month. At a current share price of €44.27 and with...
XTRA:DHER
XTRA:DHERHospitality

Uber Stake In Delivery Hero Reshapes Shareholder Mix And Future Prospects

Uber has acquired a 4.5% stake in Delivery Hero, funded by a partial sell down from major shareholder Prosus. The transaction reshapes the ownership structure of Delivery Hero and links two large global food delivery platforms. The deal draws attention to Delivery Hero’s current market valuation and its role in the competitive food delivery sector. For investors tracking XTRA:DHER, the new tie between Delivery Hero and Uber comes at a time when the share price sits at €21.19. The stock has...
XTRA:LHA
XTRA:LHAAirlines

Lufthansa’s CityLine Shutdown and Capacity Cuts Might Change The Case For Investing In Deutsche Lufthansa (XTRA:LHA)

German airline group Lufthansa has already shut down its loss-making CityLine regional subsidiary, removing its 27 aircraft from the schedule and laying off or reallocating around 2,000 employees to curb the impact of sharply higher fuel costs and labor disputes. This move highlights how Lufthansa is accelerating cost-cutting and capacity reductions, including grounding older, less efficient jets, to adapt its network to a more expensive operating backdrop. Next, we’ll examine how the...
XTRA:FRE
XTRA:FREHealthcare

A Look At Fresenius SE KGaA (XTRA:FRE) Valuation After The Latest Dividend Increase

Fresenius SE KGaA (XTRA:FRE) has announced an annual dividend of €1.05 per share, with the payout set for 27 May 2026, following an ex-dividend date of 25 May and a record date of 26 May. See our latest analysis for Fresenius SE KGaA. At a share price of €44.62, Fresenius SE KGaA has a 1 year total shareholder return of 17.09% and an 83.57% total shareholder return over three years, while the 90 day share price return of a 9.62% decline suggests some momentum has cooled despite gains over...
XTRA:SHL
XTRA:SHLMedical Equipment

Siemens Healthineers (XTRA:SHL) Valuation Check After New Oncology And AI Diagnostics Moves

Siemens Healthineers (XTRA:SHL) is back in focus after two oncology focused moves: a supply agreement for Fluorine-18 radiolabelled RAD101 in a Phase 3 brain metastases trial and new funding support for ScreenPoint Medical’s breast cancer AI platform. See our latest analysis for Siemens Healthineers. These oncology moves come as the share price trades at €38.91, with a 1 month share price return of 6.46% after a weaker 90 day period, while the 1 year total shareholder return decline of 10.78%...